Join to View Full Profile
10903 New Hampshire AveRm 2181Silver Spring, MD 20993
Phone+1 301-796-9366
Dr. Vellanki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified oncologist and I work at the FDA reviewing clinical trials for thoracic and head and neck cancers. I also care for patients with head and neck cancer in clinic at the University of Maryland, School of Medicine. My interests include cancer genetics, precision medicine, and drug development.
Education & Training
Johns Hopkins UniversityFellowship, Medical Oncology, 2017 - 2019
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2013 - 2016
University of Maryland School of MedicineClass of 2013
Certifications & Licensure
MD State Medical License 2016 - 2026
NC State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsThe Retrofit: Lessons From Sotorasib's Dosing Conundrum.Harpreet Singh, Paz J Vellanki, Richard Pazdur
Journal of Clinical Oncology. 2025-01-20 - 1 citationsPlasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group.Alexander W Wyatt, Saskia Litiere, Francois-Clément Bidard, Luc Cabel, Lars Dyrskjøt
Clinical Cancer Research. 2024-11-15 - 1 citationsEquipoise Lost? Trial Conduct Challenges in an Era of Breakthrough Therapies.Jaleh Fallah, Flora Mulkey, Mallorie H Fiero, Haley Gittleman, Chi Song
Journal of Clinical Oncology. 2024-11-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
